HA PHAM: Open Payments
NPI 1588042634 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,368 in 59 payments from 22 companies in 2025. Trend: 2023 $427 · 2024 $785 · 2025 $1,368
Food & beverage: $1,288Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $455 |
| Daiichi Sankyo Inc. | 6 | $119 |
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| Janssen Biotech, Inc. | 7 | $107 |
| GENZYME CORPORATION | 3 | $83 |
| PFIZER INC. | 3 | $61 |
| Alexion Pharmaceuticals, Inc. | 2 | $47 |
| EMD Serono, Inc. | 2 | $46 |
| JAZZ PHARMACEUTICALS INC. | 2 | $40 |
| Janssen Scientific Affairs, LLC | 1 | $36 |
Products named: IMBRUVICA, EPKINLY, Vanflyta, KISQALI, CARVYKTI, TALVEY, ULTOMIRIS, INJECTAFER.
Industry payments across OH — which companies pay providers there.
